SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950144-08-002885
Filing Date
2008-04-16
Accepted
2008-04-16 16:39:11
Documents
2
Period of Report
2008-05-21
Effectiveness Date
2008-04-16

Document Format Files

Seq Description Document Type Size
1 BIOCRYST PHARMACEUTICALS, INC. g12722def14a.htm DEF 14A 545884
2 GRAPHIC g12722g1272200.gif GRAPHIC 3542
  Complete submission text file 0000950144-08-002885.txt   552363
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 08760162
SIC: 2836 Biological Products, (No Diagnostic Substances)